1 patient evaluation for Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) with a adherence rating of Usually
2 members have decided to share their profiles only with other members of PatientsLikeMe.
Sort by:
Most recent
Dec 5, 2011 (Started Dec 03, 2003)
-
EffectivenessMajor (for human immunodeficiency virus (HIV))
-
Side effectsMild (nausea)
-
AdherenceUsually
-
BurdenNot at all hard to take
Dosage:
2 x 300 mg-150 mg-300 mg
Daily
Side effects:
nausea
Aug 29, 2010 (Started Dec 03, 2003)
-
EffectivenessModerate (for human immunodeficiency virus (HIV))
-
Side effectsMild (nausea)
-
AdherenceUsually
-
BurdenNot at all hard to take
Dosage:
2 x 300 mg-150 mg-300 mg
Daily
Side effects:
nausea
- 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV)